Related Experiment Videos
Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case
H J Ankersmit1, R Ullrich, B Moser
1Department of Cardiothoracic Surgery, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria. hjankersmit@hotmail.com
Insights
Giant cell myocarditis (GCM) is a rare, fatal heart condition. This case study shows extracorporeal membrane oxygenation (ECMO) and rabbit antithymocyte globulin (rATG) can be life-saving treatments for GCM-induced cardiogenic shock.
Area of Science:
- Cardiology
- Immunology
Background:
- Giant cell myocarditis (GCM) is a rare and often fatal cardiac condition.
- GCM commonly leads to ventricular arrhythmias and congestive heart failure.
Observation:
- A patient presented with cardiogenic shock and histologically confirmed GCM.
- The patient's critical condition necessitated immediate intervention.
Findings:
- Life-saving treatment involved extracorporeal membrane oxygenation (ECMO) combined with rabbit antithymocyte globulin (rATG), cyclosporine, and steroids.
- At 12 months post-treatment, the patient demonstrated NYHA class I heart function with moderate left ventricular impairment (EF 55%).
Implications:
- This case highlights the potential of ECMO and rATG as a life-saving strategy for GCM-related cardiogenic shock.
- Further clinical studies investigating rATG for GCM treatment are warranted.
Abstract:
Giant cell myocarditis (GCM) is a rare and frequently fatal disorder. Patients suffer of ventricular arrhythmias or congestive heart failure. Here we describe a patient with cardiogenic shock and histological verified GCM. The patient was saved by implantation of extracorporeal membrane oxygeneation (ECMO) device and concomitant application of Rabbit antithymocyte globuline (rATG, Thymoglobulin, Sangstat), cyclosporine, and steroids in the acute event. 12 months after the crisis the patient evidences NYHA class I heart function and only a moderate impairment of heart function (EF 55%). The novel utilisation of ECMO in GCM related cardiogenic shock and application of rATG have prooven life-saving in this patient. Studies utilizing rATG in the treatment of GCM are warrented.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care